Analytical Balances: New USP Proposals on Qualification
![Stability Studies to Support Shipping/Distribution of Pharmaceuticals and Biopharmaceuticals - Live Online Training](files/eca/userImages/training.img/Z-ECA-Stability-Studies-Shipping-Distribution-LOT.jpg)
Recommendation
12/13 September 2024
In the Pharmacopeial Forum 38/5 two proposals have been published about the revision of the two General Chapters on analytical balances.
It is planned to replace the title of General Chapter <41> "Weights and Balances" by "Balances" and also to revise General Chapter <1251> "Weighing on an Analytical Balance".
Chapter <1251> provides background information and advice regarding the qualification of analytical balances - also in concrete terms for OQ and PQ including possible tests. Unlike General Chapter <41>, Chapter <1251> isn't binding.
Regarding the fundamental approach for qualification it is referred to USP Chapter <1058> on Analytical Instrument Qualification.
In the future, the USP requirements on analytical balances will be slightly modified. The new USP requirements apply to all balances used for materials that must be "accurately weighed" (according to General Notices, 8.20).
Among other things the repeatability requirement has been changed from 0.1% to 0.10% in order to reflect current metrology practices.
A test weight should have a nominal mass between 5% and 100% of the balance's capacity.
Both the current USP requirements on Analytical Instrument Qualification and the concrete guidelines regarding handling and analytical instrument qualification will be important topics presented during ECA's Education Course "Analytical Instrument Qualification" from 20-22 February 2013 in Barcelona, Spain.
More details about these two USP General Chapters <41< and <1251> can be found in the online edition of the PF.
Related GMP News
24.07.2024FDA Warning Letter to Chinese OTC Manufacturer for Lack of Analytical Test Data
10.07.2024Pharmeuropa: Two Revised Chapters on Dissolution Testing published for comments
03.07.2024FDA Warning Letter: GMP Requirements also apply to HPLC Analyses for Internal Use
12.06.2024NMPA Announcement on Application of ICH Q2(R2) and Q14 Principles
22.05.2024Q&As from the Live Online Training "Introduction to the AQCG's new AIQSV Guide" - Part 1
22.05.2024FDA Warning Letter to Contract Testing Laboratory in Uruguay due to Data Integrity Violations